US 12258333
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
granted A61PA61P29/00
Quick answer
US patent 12258333 (N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P29/00